Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 48 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 46 | 1,360−6.9%/yr | −6.9%/yr | 2.30.7× | 5% | 1,720 in 2030+4%/yr |
| Lumbar fusion | 22 | 934−3.1%/yr | −3.1%/yr | 1.60.6× | 5% | 1,390 in 2030+6.8%/yr |
| Kyphoplasty & vertebroplasty | 5 | 577−4.4%/yr | −4.4%/yr | 1.00.7× | 12% | 650 in 2030+2%/yr |
| Cervical fusion & disc arthroplasty | 3 | 479−5.3%/yr | −5.3%/yr | 0.80.6× | 4% | 730 in 2030+7.3%/yr |
| SI joint fusion | 3 | 135+14%/yr | +14%/yr | 0.21.0× | 100% | 140 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 223 | 33,585−4.1%/yr | −4.1%/yr | 56.50.7× | 40% | 38,900 in 2030+2.5%/yr |
| Skin substitutes & wound grafts | 12 | 3,903−0.1%/yr | −0.1%/yr | 3.90.5× | 25% | 4,360 in 2030+1.8%/yr |
| Bone graft & orthobiologics | 4 | 304−9.5%/yr | −9.5%/yr | 0.50.8× | 1% | 360 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 107 | 5,630−0.5%/yr | −0.5%/yr | 9.51.1× | 45% | 6,580 in 2030+2.6%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 8 | 775+8.3%/yr | +8.3%/yr | 1.31.2× | 50% | 1,500 in 2030+12%/yr |
| Spinal cord & DRG stimulation | 10 | 363−4.6%/yr | −4.6%/yr | 0.60.8× | 50% | 420 in 2030+2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 23 | 2,016−15%/yr | −15%/yr | 3.70.8× | 42% | 1,940 in 2030−0.6%/yr |
| Peripheral arterial intervention | 15 | 1,979−9.4%/yr | −9.4%/yr | 3.30.8× | 2% | 2,150 in 2030+1.4%/yr |
| Superficial venous ablation | 10 | 1,300−2.6%/yr | −2.6%/yr | 2.20.6× | 73% | 1,100 in 2030−2.8%/yr |
| Carotid revascularization | 15 | 618−4.6%/yr | −4.6%/yr | 1.10.9× | 0% | 730 in 2030+2.8%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 601−4.2%/yr | −4.2%/yr | 1.10.7× | 5% | 1,010 in 2030+9.1%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 197−8.5%/yr | −8.5%/yr | 0.40.7× | 0% | 270 in 2030+5.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 34 | 3,364−3.4%/yr | −3.4%/yr | 6.41.0× | 3% | 3,770 in 2030+1.9%/yr |
| Cholecystectomy & appendectomy | 20 | 2,445−4.2%/yr | −4.2%/yr | 4.51.0× | 1% | 2,580 in 2030+0.9%/yr |
| Colorectal resection | 1 | 955−4%/yr | −4%/yr | 1.71.0× | 0% | 1,070 in 2030+1.9%/yr |
| Antireflux & hiatal hernia surgery | 6 | 452−0.5%/yr | −0.5%/yr | 0.81.0× | 0% | 590 in 2030+4.6%/yr |
| Breast reconstruction | 0 | 200−7%/yr | −7%/yr | 0.40.8× | 0% | 210 in 2030+1%/yr |
| Bariatric surgery | 3 | 135−2.7%/yr | −2.7%/yr | 0.21.2× | 0% | 100 in 2030−4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 63 | 2,490−3.4%/yr | −3.4%/yr | 4.50.8× | 6% | 2,900 in 2030+2.6%/yr |
| BPH procedures | 40 | 2,152−11%/yr | −11%/yr | 3.80.8× | 14% | 2,150 in 20300%/yr |
| Hysterectomy, hysteroscopy & ablation | 12 | 1,602−0.7%/yr | −0.7%/yr | 3.11.1× | 7% | 1,910 in 2030+3%/yr |
| Incontinence, prolapse & sacral neuromodulation | 13 | 1,066+0.3%/yr | +0.3%/yr | 1.90.8× | 3% | 1,370 in 2030+4.2%/yr |
| Prostatectomy & nephrectomy | 15 | 741−1.7%/yr | −1.7%/yr | 1.51.0× | 0% | 1,000 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 14 | 2,675+8.3%/yr | +8.3%/yr | 4.81.4× | 79% | 4,240 in 2030+8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 59 | 3,773−5.8%/yr | −5.8%/yr | 7.21.0× | 14% | 4,380 in 2030+2.5%/yr |
| Tumor & fibroid embolization | 4 | 296+1.8%/yr | +1.8%/yr | 0.51.0× | 0% | 330 in 2030+1.9%/yr |
| Tumor ablation | 3 | 239−0.5%/yr | −0.5%/yr | 0.41.4× | 0% | 180 in 2030−5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 144 | 12,963+33%/yr | +33%/yr | 22.50.8× | 71% | 25,100 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 51 | 2,533−2.6%/yr | −2.6%/yr | 4.70.9× | 0% | 2,880 in 2030+2.1%/yr |
| EP ablation | 48 | 1,918+11%/yr | +11%/yr | 2.80.9× | 0% | 3,690 in 2030+12%/yr |
| LAA occlusion & loop recorders | 50 | 1,796+14%/yr | +14%/yr | 2.70.9× | 0% | 3,250 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 82 | 3,280−8.3%/yr | −8.3%/yr | 4.60.8× | 0% | 3,530 in 2030+1.2%/yr |
| Structural heart (TAVR, TEER) | 64 | 1,422+6.9%/yr | +6.9%/yr | 2.11.2× | 0% | 1,970 in 2030+5.6%/yr |
| Mechanical circulatory support | 0 | 301−5.6%/yr | −5.6%/yr | 0.50.8× | 0% | 300 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 8 | 221−2.1%/yr | −2.1%/yr | 0.41.0× | 0% | 160 in 2030−5.4%/yr |
| DBS & VNS | 3 | 158−3.1%/yr | −3.1%/yr | 0.30.8× | 0% | 140 in 2030−2.5%/yr |
| Aneurysm & intracranial embolization | 2 | 154+1.5%/yr | +1.5%/yr | 0.30.6× | 0% | 470 in 2030+20%/yr |
| CSF shunts | 0 | 105+1.8%/yr | +1.8%/yr | 0.21.0× | 0% | 120 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 145 | 38,264+1.4%/yr | +1.4%/yr | 66.51.0× | 58% | 52,200 in 2030+5.3%/yr |
| Vitreoretinal surgery | 18 | 1,472−1%/yr | −1%/yr | 2.61.1× | 29% | 1,730 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 332 | 60,336−2.2%/yr | −2.2%/yr | 111.61.0× | 20% | 63,900 in 2030+1%/yr |
| Bronchoscopy & lung nodule | 40 | 2,262+6.8%/yr | +6.8%/yr | 4.11.1× | 1% | 4,120 in 2030+11%/yr |
| ERCP & endoscopic ultrasound | 40 | 1,723−4.1%/yr | −4.1%/yr | 3.10.8× | 0% | 1,930 in 2030+1.9%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.